On April 11, 2024, Merck & Co., Inc announced that it has received a shareholder proposal from The Bahnsen Family Trust requesting the Company Board to conduct an evaluation and issue a civil rights and non-discrimination report within the next year, at reasonable cost and excluding proprietary information and disclosure of anything that would constitute an admission of pending litigation, evaluating how the Company?s policies and practices impact employees and prospective employees based on their religion (including religious views) or political views, and the risks those impacts present to the Company?s business. In addition, the Company urged the shareholders to vote against the proposal at its annual general meeting of shareholders scheduled to be held on May 28, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.1 USD | -0.82% | +2.51% | +19.35% |
Apr. 29 | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
Apr. 29 | Blackstone beats Concord with $1.6 bln bid for Hipgnosis Songs | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.35% | 332B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B | |
-10.94% | 144B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co Receives a Shareholder Proposal from The Bahnsen Family Trust